Inhibrx Biosciences, Inc. Profile Avatar - Palmy Investing

Inhibrx Biosciences, Inc.

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate tar…

Biotechnology
US, La Jolla [HQ]

Lobbying Analysis

Inhibrx Biosciences, Inc. has no lobbying expenses in our database.

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
No data
End of INBX's Analysis
CIK: 1739614 CUSIP: 45720L107 ISIN: US45720L1070 LEI: - UEI: -
Secondary Listings
INBX has no secondary listings inside our databases.